Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Stone, Kidney
Total 0 results
Nothing found
Sponsors and Collaborators
Agency for Science, Technology and Research
iCAD
Apollo Neuroscience, Inc.
Everett Meyer
Aptis Medical
Hospital Durand, Argentina
GFI
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Eurofins Genoma
ASST Cremona, Cremona
Nacuity Pharmaceuticals, Inc.
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Neurophth Therapeutics Inc
Alma Lasers Inc.
Hospital ASEPEYO Sant Cugat
Kupfer, David J., M.D.
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Korean Society of Spine Surgery
Mª Victoria Maestre Sanchez
RMIT University, Melbourne, Australia
View Full List
Medical Conditions
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Recurrent Clear Cell Sarcoma of Soft Tissue
Major Liver Surgery
Treatment Decisions
Corneal Cross-Linking
Splenic Trauma
Chronic Constipation Symptoms
Scleredema
Immune-Mediated Inflammatory Disease
T-LGL Leukemia
RISS Stage III Plasma Cell Myeloma
Rheumatoid Arthritis(RA)
Metachronous Adenoma
Dienogest
The Strength Properties of the Aorta in Vitro
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Luteal Phase Support
Fever
Disorder of Fluid Balance
Gastric Cancer Stage IIIB-IIIC
View Full List
Drug Interventions
Olopatadine
Desvenlafaxine
OnabotulinumtoxinA
Intravenous deferiprone
Letrozole
Midazolam
MLN2480
RDX227675
THC
TPN-101
Standard of care (SOC) for COVID-19
GLPG1837 multiple ascending doses
Capecitabine/cisplatin
Camptosar
Capecitabine and IMRT (if randomized to this arm)
Intravenous Formulation of PD-0332991
Oxycodone/acetaminophen 5/325 mg
PD-1/PD-L1 inhibitor
Anticholinergic
Fospropofol disodium, propofol
View Full List
CROs by country
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Croatia
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Germany
Contract Research Organizations in Italy
Contract Research Organizations in Jordan
Contract Research Organizations in Myanmar
Contract Research Organizations in Netherlands
Contract Research Organizations in Oman
Contract Research Organizations in Qatar
Contract Research Organizations in Taiwan
Contract Research Organizations in United Arab Emirates
Contract Research Organizations in United Kingdom
CRO list by country
CROs in Mongolia
SGS
All CROs in Mongolia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe